The US drugs giant will use proceeds from its second sustainability bond issue to tackle the pandemic, including in emerging markets. ESG head Chris Gray seeks to dispel scepticism by explaining the deal's rationale, while treasurer Brian McMahon discusses the $1bn bond’s pricing.
SDG 3: Good health and well being
Medical device maker Nipro has become a rare Japanese issuer of a sustainability-linked loan, and the first from the healthcare sector. Disclosed details are limited, but it aims to use the proceeds to help address Covid-19 issues and generally improve public health both domestically and overseas.
The region's healthcare providers have been slow to embrace sustainable funding because it is tricky to set measurable key performance indicators in the sector – but that is changing.